145 related articles for article (PubMed ID: 16465962)
1. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
[TBL] [Abstract][Full Text] [Related]
2. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
[TBL] [Abstract][Full Text] [Related]
3. The REGICOR-calibrated function provides a better classification of high-risk patients on statin treatment in the Spanish population than the Framingham or SCORE classifications.
Baena-Díez JM; Grau M; Sánchez-Pérez R; Altes-Vaques E; Salas-Gaetjens LH; Hernández-Ibáñez MR
Rev Esp Cardiol; 2009 Oct; 62(10):1134-40. PubMed ID: 19793519
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
[TBL] [Abstract][Full Text] [Related]
5. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
[TBL] [Abstract][Full Text] [Related]
6. [Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population].
Gil-Guillén V; Orozco-Beltrán D; Maiques-Galán A; Aznar-Vicente J; Navarro J; Cea-Calvo L; Quirce-Andrés F; Redón J; Merino-Sánchez J
Rev Esp Cardiol; 2007 Oct; 60(10):1042-50. PubMed ID: 17953925
[TBL] [Abstract][Full Text] [Related]
7. [Carotid intima-media thickness distribution according to the stratification of cardiovascular risk by means of Framingham-REGICOR and score function charts].
Hermida-Ameijeiras Á; López-Paz JE; Riveiro-Cruz MA; Calvo-Gómez C
Hipertens Riesgo Vasc; 2016; 33(2):51-7. PubMed ID: 26796100
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].
Buitrago Ramírez F; Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Bravo Simón B; Pérez Sánchez I
Med Clin (Barc); 2006 Sep; 127(10):368-73. PubMed ID: 16987481
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the SCORE and Framingham models in calculating high cardiovascular risk for a sample of males within the 45-65 age range in Asturias, Spain].
Alvarez Cosmea A; Díaz González L; López Fernández V; Prieto Díaz MA; Suárez García S
Rev Esp Salud Publica; 2005; 79(4):465-73. PubMed ID: 16465963
[TBL] [Abstract][Full Text] [Related]
10. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.
Buitrago F; Calvo-Hueros JI; Cañón-Barroso L; Pozuelos-Estrada G; Molina-Martínez L; Espigares-Arroyo M; Galán-González JA; Lillo-Bravo FJ
Ann Fam Med; 2011; 9(5):431-8. PubMed ID: 21911762
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular disease.
Jansen-Chaparro S; Mancera J; Cuende JI; Villalobos A; Baca AJ; Lopez-Carmona MD; Bernal-Lopez MR; Tinahones FJ; Gomez-Huelgas R
Eur J Intern Med; 2012 Sep; 23(6):558-63. PubMed ID: 22863435
[TBL] [Abstract][Full Text] [Related]
12. [Estimating cardiovascular risk in Spain using different algorithms].
Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
[TBL] [Abstract][Full Text] [Related]
13. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of coronary risk estimates derived using the Framingham and REGICOR equations].
Cristóbal J; Lago F; de la Fuente J; González-Juanatey JR; Vázquez-Bellés P; Vila M
Rev Esp Cardiol; 2005 Aug; 58(8):910-5. PubMed ID: 16053824
[TBL] [Abstract][Full Text] [Related]
15. [Framingham function estimates the risk of cardio vascular mortality more effectively than SCORE function in the population of the Canary Islands (Spain)].
Cabrera de León A; Alemán Sánchez JJ; Rodríguez Pérez MC; del Castillo-Rodríguez JC; Domínguez-Coello S; Almeida-González D; Anía Lafuente B; Aguirre Jaime A; Brito Díaz B
Gac Sanit; 2009; 23(3):216-21. PubMed ID: 19250709
[TBL] [Abstract][Full Text] [Related]
16. [The use of the Framingham-REGICOR equation in a primary care centre. Impact on primary prevention of cardiovascular diseases].
Parrilla Valero F; Segura Benedicto A; Segú Tolsa JL
Aten Primaria; 2006 Nov; 38(9):490-5. PubMed ID: 17194352
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and validation of cardiovascular risk prediction functions in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (SPAIN). AN observational study.
Calvo-Hueros JI; Cañón-Barroso L; Morales-Gabardino JA; Buitrago F
Prim Care Diabetes; 2021 Feb; 15(1):115-120. PubMed ID: 32811775
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].
Ramos R; Solanas P; Cordón F; Rohlfs I; Elosua R; Sala J; Masiá R; Faixedas MT; Marrugat J
Med Clin (Barc); 2003 Oct; 121(14):521-6. PubMed ID: 14599406
[TBL] [Abstract][Full Text] [Related]
19. [A comparative assessment of the cardiovascular risk in open Spanish population using four approaches].
López-González AA; Vicente-Herrero MT
Rev Med Inst Mex Seguro Soc; 2011; 49(3):267-71. PubMed ID: 21838993
[TBL] [Abstract][Full Text] [Related]
20. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
